CompaniesByCap
ALLR
Allarity Therapeutics Inc. (ALLR)
NASDAQ · Healthcare

Allarity Therapeutics Inc. Revenue 2024–2025

Allarity Therapeutics Inc. annual/quarterly revenue history and growth rate from 2024 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Allarity Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 25000.
  • Allarity Therapeutics Inc. annual revenue for 2025 was 320000.
  • Allarity Therapeutics Inc. annual revenue for 2024 was 0.
Revenue
QUARTERLY · $B

Allarity Therapeutics Inc. (ALLR) — Frequently Asked Questions

Allarity Therapeutics Inc. (ALLR) is a publicly traded US company. It has a market capitalization of $24M. In fiscal 2025 it reported revenue of $320,000 and net income of -$11M. Explore ALLR's stock price, financial statements, earnings history, margins and key ratios below.

What is Allarity Therapeutics Inc.'s market cap?

Allarity Therapeutics Inc. (ALLR) has a market capitalization of $24M.

What is the ALLR stock price?

ALLR trades at $1.49 (-7.45% on the day).

How much revenue does Allarity Therapeutics Inc. make?

Allarity Therapeutics Inc. reported revenue of $320,000 in fiscal 2025.

Is ALLR profitable?

In fiscal 2025, Allarity Therapeutics Inc. reported net income of -$11M.